CS logo
small CS logo
The Children's Hospital for Cancer and Blood Disorders

Aurora, Colorado, United States
Hospital in Aurora, Colorado
13123 E 16th Ave, Aurora, CO 80045
434 Beds

About The Children's Hospital for Cancer and Blood Disorders


Children's Hospital Colorado is an academic pediatric acute care children's hospital located in the Anschutz Medical Campus near the interchange of I-225 and Colfax Avenue in Aurora, Colorado. The hospital has 434 pediatric beds at its main campus in Aurora.
There are 434 beds in The Children's Hospital for Cancer and Blood Disorders.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at The Children's Hospital for Cancer and Blood Disorders


During the past decade, The Children's Hospital for Cancer and Blood Disorders conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Ixabepilone in Treating Patients With Metastatic Prostate Cancer
2004-09-01
2011-02-01
Completed
124
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
2006-01-01
2014-11-01
Completed
1,145
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
2006-02-01
2010-08-01
Terminated
402
A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma
2005-12-01
2009-05-01
Completed
50
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355

Rows per page:

1–15 of 15

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "The Children's Hospital for Cancer and Blood Disorders" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Innovative Therapies for Children with Cancer in Europe (ITCC)" with 1 trials as a collaborator and "New Approaches to Neuroblastoma Therapy Consortium (NANT)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at The Children's Hospital for Cancer and Blood Disorders


According to Clinical.Site data, the most researched conditions in "The Children's Hospital for Cancer and Blood Disorders" are "Infantile Fibrosarcoma" (1 trials), "Infantile Myofibromatosis" (1 trials), "Medullary Thyroid Cancer" (1 trials), "Neoplasm Metastasis" (1 trials) and "Neuroblastoma" (1 trials). Many other conditions were trialed in "The Children's Hospital for Cancer and Blood Disorders" in a lesser frequency.

Clinical Trials Intervention Types at The Children's Hospital for Cancer and Blood Disorders


Most popular intervention types in "The Children's Hospital for Cancer and Blood Disorders" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials), "Ifosfamide" (1 trials), "Irinotecan" (1 trials) and "LOXO-292" (1 trials). Other intervention names were less common.

Clinical Trials Genders at The Children's Hospital for Cancer and Blood Disorders


The vast majority of trials in "The Children's Hospital for Cancer and Blood Disorders" are 3 trials for "All" genders.

Clinical Trials Status at The Children's Hospital for Cancer and Blood Disorders


Currently, there are NaN active trials in "The Children's Hospital for Cancer and Blood Disorders". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in The Children's Hospital for Cancer and Blood Disorders, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Children's Hospital for Cancer and Blood Disorders, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status